US 12,138,413 B2
Optimized intrathecal drug delivery
Jeffrey Bodner, Plymouth, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Dec. 20, 2021, as Appl. No. 17/556,574.
Application 17/556,574 is a continuation of application No. 16/444,209, filed on Jun. 18, 2019, granted, now 11,229,778.
Claims priority of provisional application 62/687,889, filed on Jun. 21, 2018.
Prior Publication US 2022/0111188 A1, Apr. 14, 2022
Int. Cl. A61M 31/00 (2006.01)
CPC A61M 31/002 (2013.01) [A61M 2205/04 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3523 (2013.01); A61M 2205/50 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2210/1003 (2013.01); A61M 2230/06 (2013.01); A61M 2230/205 (2013.01); A61M 2230/40 (2013.01); A61M 2230/62 (2013.01); A61M 2230/63 (2013.01)] 29 Claims
OG exemplary drawing
 
1. A medical system configured to selectively deliver therapy based on one or more sensed physiological conditions of a patient, the medical system comprising:
an implantable medical device configured to selectively deliver therapy to the patient, wherein the implantable medical device is programmable with a treatment protocol specifying at least one window of time during which a therapeutic treatment is to be administered, wherein administration of the therapeutic treatment within the at least one window of time is triggered by a change in one or more sensed physiological conditions of the patient, and wherein the system collects data and uses a predictive algorithm to suggest moving at least one window of time earlier or later in the day or increasing the duration of at least one window of time to coincide with a pattern of a sensed physiological condition.